Evaluation of a pharmacist-led medication therapy management program for patients with hypertension at a tertiary hospital’s outpatient clinic in Malawi
| dc.contributor.author | Msowoya, Denise | |
| dc.date.accessioned | 2021-12-22T10:36:39Z | |
| dc.date.available | 2021-12-22T10:36:39Z | |
| dc.date.issued | 2020-10-16 | |
| dc.description.abstract | Type of Study: Prospective Parallel Cohort Study Problem: Non-Communicable Diseases (NCDs) are causing significant morbidity and mortality within Malawi’s population. In particular, hypertension is a chronic health problem that often is under prioritized due to high prevalence of infectious diseases. The pharmacy profession is underutilized in efforts to address hypertension in the public health system due to gaps in data supporting ambulatory pharmacists’ inclusion in treatment. Objectives: This parallel cohort study intends to evaluate blood pressure control and adherence in patients receiving standard of care compared to patients receiving standard of care in addition to an ambulatory care pharmacist’s services in a hypertension clinic. Secondary objectives include evaluating goal blood pressure met in both study arms, determining types and quantity of pharmacist interventions, and collecting data on satisfaction and feedback from other healthcare professionals and patients. Methodology: A trained ambulatory care pharmacist will be incorporated into the hypertension clinic at Queen Elizabeth Central Hospital (QECH) from November 2020 to November 2021. There will be two arms of the study: the control arm being standard of care offered at the clinic, the intervention arm being standard of care plus the services of the aforementioned ambulatory care pharmacists. This pharmacist will collect baseline demographic data and treatment status along with treatment progression at follow-ups per the hypertension clinic’s guidelines. Medication adherence will also be monitored between both groups by the pharmacist. Patient satisfaction scores and feedback from the other members of the healthcare team will be collected throughout the study. Analysis of blood pressure changes, patients achieving goal blood pressure, and change in medication adherence will be conducted at 6 months and 12 months. Expected Findings: The expected outcomes will display a statistically significant benefit in health outcomes and adherence through the incorporation of an ambulatory pharmacist compared to the current standard of care. These results will also reveal patient satisfaction scores and healthcare provider feedback that will promote future inclusion of pharmacists in NCD outpatient treatment. Dissemination: The results will be presented at the 2021 International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Seville, Spain. The associated manuscript will be submitted to the peer reviewed Journal of Pharmacy Practice for publication. In addition, the results will be presented to the Malawi Ministry of Health by the pharmacy department at the College of Medicine to open discussion about creating ambulatory pharmacist positions. Finally, the results will be shared with COMREC upon the completion of the study. | en_US |
| dc.description.sponsorship | Kamuzu University of Health Sciences Queen Elizabeth Central Hospital (QECH) University of North Carolina Project, Malawi | en_US |
| dc.identifier.uri | http://rscarchive.kuhes.ac.mw/handle/20.500.12988/790 | |
| dc.language.iso | en | en_US |
| dc.publisher | Kamuzu University of Health Sciences | en_US |
| dc.relation.ispartofseries | Protocol;P.09/20/3128 | |
| dc.title | Evaluation of a pharmacist-led medication therapy management program for patients with hypertension at a tertiary hospital’s outpatient clinic in Malawi | en_US |
| dc.type | Plan or blueprint | en_US |